International Partners into Indian Biotech Firms
International Partners into Indian Biotech Firms


Although being on the ‘threshold of biotech revolution’. India has fallen behind Chinese and American companies in infrastructure and manufacturing. A market research report namely, Indian Biotech Industry Profile (2005) published by RNCOS, estimate this industry to reach $5 billion (Rs 22,000 crore) by 2010. However, the industry which, has developed competence in pharmaceuticals and drug development, fear loss of patent rights which can lead to discovery of generic drugs.



The Indian biotech industry confronts several challenges. First there is no increase in its budgets unlike in other major economies. Secondly, these activities could diminish the limited resources. And finally, in spite of high development of clinical activity, co-development would be the emphasizing factor.



India now seeks new partners with Chinese and European firms apart from the US. RNCOS’ market research report points out that the partnering in the biotech sector could alleviate poverty in India through effective medicine and improvements in agricultural and industrial productions. And, it discusses the success of biotech collaboration in terms of business, export and economic stability in the country.


Biotech News

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech